Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01186198 · ClinicalTrials.gov registry record

A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter in Stenotic Lesions

A clinical trial of Ischemic Heart Disease and Coronary Artery Stenosis, sponsored by Abbott Medical Devices.

Completed
Registry status
71
Enrollment target
4
Study locations

NCT01186198 is a study of Ischemic Heart Disease and Coronary Artery Stenosis that has completed, run by Abbott Medical Devices. The registered enrollment target is 71 participants, below the 261-participant average among 14 other Ischemic Heart Disease trials with a reported enrollment target (73% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01186198, a study of Ischemic Heart Disease and Coronary Artery Stenosis, has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
71 participants
Enrollment target
4
Study locations

Study Summary

This is a prospective, single-arm, open-label, multi-center, observational study to assess the acute safety and efficacy of MINI TREK RX 1.20 mm for enlarging coronary luminal diameter during percutaneous coronary intervention (PCI) procedures in subjects with ischemic heart disease due to stenotic lesions.

Conditions Studied

Ischemic Heart Disease Coronary Artery Stenosis Coronary Bypass Graft Stenosis Chronic Coronary Total Occlusion

Interventions

  • DEVICE MINI TREK RX 1.20 mm Coronary Dilatation Catheter

Study Locations (4)

California

  • Scripps Green Hospital - La Jolla

Maryland

  • Peninsula Regional Medical Center - Salisbury

Michigan

  • Northern Michigan Hospital - Petoskey

Ohio

  • The Christ Hospital - Cincinnati

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2010-08-12
Est. Completion 2010-12-30

Sponsor

Abbott Medical Devices

261 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01186198

The ClinicalTrials.gov registry entry for NCT01186198 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 14 other Ischemic Heart Disease trials with a reported enrollment target (73% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Ischemic Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which MINI TREK RX 1.20 mm Coronary Dilatation Catheter is the first listed.

NCT01186198 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Maryland, Michigan.

Frequently Asked Questions

What is clinical trial NCT01186198 about?

NCT01186198 is a clinical study titled "A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter in Stenotic Lesions". This is a prospective, single-arm, open-label, multi-center, observational study to assess the acute safety and efficacy of MINI TREK RX 1.20 mm for enlarging coronary luminal diameter during percutaneous coronary intervention (PCI) procedures in subjects with ischemic heart disease due to stenotic ...

What is the current status of trial NCT01186198?

This trial is currently completed. The enrollment target is 71 participants. The study started on 2010-08-12. Estimated completion is 2010-12-30.

What conditions does trial NCT01186198 study?

This clinical trial studies the following conditions: Ischemic Heart Disease, Coronary Artery Stenosis, Coronary Bypass Graft Stenosis, Chronic Coronary Total Occlusion.

What interventions are being tested in trial NCT01186198?

The interventions under investigation include: MINI TREK RX 1.20 mm Coronary Dilatation Catheter (DEVICE).

Who is sponsoring clinical trial NCT01186198?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01186198 being conducted?

This trial has 4 study locations across California, Maryland, Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ischemic Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ischemic Heart Disease

All registered trials for this condition

Coronary Artery Stenosis

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.